|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product revenue | |||||
| Service revenue | |||||
| Total revenues | |||||
| Cost of revenue | |||||
| Product revenue | |||||
| Service revenue | |||||
| Total cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| General and administrative | |||||
| Impairment on intangibles | |||||
| Acquisition related costs | |||||
| Sales and marketing | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Other income | |||||
| Interest expense | |||||
| Amortization of debt issue costs | |||||
| Loss on debt extinguishment | |||||
| Interest income | |||||
| Total other expense | |||||
| Loss before income tax | |||||
| Income tax expense | |||||
| Net Income Loss | |||||
| Basic net loss per share attributable to common shareholders | |||||
| Weighted-average common shares outstanding | |||||
| Diluted net loss per share | |||||
| Weighted-average common shares and share equivalents outstanding |
Loading...